Anti-inflammatory effect of oxytocin in rat myocardial infarction
- 768 Downloads
While an increasing amount of evidence demonstrates the homeostatic functions of the cardiac oxytocin (OT) system, less is known about the role of this hormone in the injured heart. The current study examined the effect of OT infusion on cell apoptosis, expression of proliferating cell nuclear antigen (PCNA) and inflammation in the acute and subacute phases of myocardial infarction (MI). Prior MI male Sprague-Dawley rats were infused subcutaneously with OT 25 or 125 ng/(kg h) for 3 or 7 days. Saline-treated MI and sham-operated rats served as controls. Echocardiography and analysis of cardiac sections were used to disclose OT actions. Left ventricular fractional shortening, estimated to be 46.0 ± 1.8% in sham controls, declined to 21.1 ± 3.3% in vehicle-treated MI rats and was improved to 34.2 ± 2.1 and to 30.9 ± 2.5% after treatment with OT 25 and 125 ng/(kg h), respectively. OT infusion resulted in: (1) increase of cells expressing PCNA in the infarct zone, diminished cell apoptosis and fibrotic deposits in the remote myocardium; (2) suppression of inflammation by reduction of neutrophils, macrophages and T lymphocytes; (3) depression of the expression of proinflammatory cytokines tumor necrosis factor-alpha and interleukin-6 with promotion of transforming growth factor-beta. OT treatment reduced expression of atrial and brain natriuretic peptides in the infarcted ventricle, as well as the concentration of both peptides in the circulation. These results indicate that continuous OT delivery reduces inflammation and apoptosis in infarcted and remote myocardium, thus improving function in the injured heart.
KeywordsOxytocin Myocardial infarction Inflammation Apoptosis
We appreciate the editorial assistance of Ovid da Silva (Research Support Office, CHUM, Hôtel-Dieu Research Center) as well as the secretarial help of Jennifer Lelievre. This work was supported by the Canadian Institutes of Health Research (MOP-53217 to J. G., G. B. and M. J.); and the Canadian Heart and Stroke Foundation (NET SRD-63193 to J. G., G. B. and M. J.).
- 9.Chorianopoulos E, Heger T, Lutz M, Frank D, Bea F, Katus HA, Frey N (2009) FGF-inducible 14-kDa protein (Fn14) is regulated via the RhoA/ROCK kinase pathway in cardiomyocytes and mediates nuclear factor-kappaB activation by TWEAK. Basic Res Cardiol [Epub ahead of print]. doi: 10.1007/s00395-009-0046-y
- 15.Florian M, Jankowski M, Gutkowska J (2010) Oxytocin regulates glucose uptake in neonatal rat cardiomyocytes. Endocrinology. doi: 10.1210/en.2009-0624
- 17.Frangogiannis NG, Lindsey ML, Michael LH, Youker KA, Bressler RB, Mendoza LH, Smith CW, Entman ML (1998) Resident cardiac mast cells degranulate and release preformed TNF-alpha, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion. Circulation 98:699–710PubMedGoogle Scholar
- 35.Kobayashi H, Yasuda S, Bao N, Iwasa M, Kawamura I, Yamada Y, Yamaki T, Sumi S, Ushikoshi H, Nishigaki K, Takemura G, Fujiwara T, Fujiwara H, Minatoguchi S (2009) Post-infarct treatment with oxytocin improves function and remodeling via activating cell survival signals and angiogenesis. J Cardiovascul Pharmacol [Epub ahead of print]. doi: 10.1097/FJC.0b013e3181bfac02
- 42.Nagoshi T, Matsui T, Aoyama T, Leri A, Anversa P, Li L, Ogawa W, del Monte F, Gwathmey JK, Grazette L, Hemmings BA, Kass DA, Champion HC, Rosenzweig A (2005) PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury. J Clin Invest 115:2128–2138CrossRefPubMedGoogle Scholar
- 59.Tiede K, Melchior-Becker A, Fischer JW (2009) Transcriptional and posttranscriptional regulators of biglycan in cardiac fibroblasts. Basic Res Cardiol. doi: 10.1007/s00395-009-0049-8